Over 95% individuals developed antibodies against the Sinopharm vaccine – USJ researchers

A Sri Lankan study has found that the Sinopharm vaccine appeared to produce high immunity against the Coronavirus and induce a similar level of antibody response against B.1.617.2 (Delta) and B.1.351 (Beta) variants of the virus as seen following natural infection. MORE..